0000899243-19-012933.txt : 20190509
0000899243-19-012933.hdr.sgml : 20190509
20190509200124
ACCESSION NUMBER: 0000899243-19-012933
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190507
FILED AS OF DATE: 20190509
DATE AS OF CHANGE: 20190509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tovey Christopher J.
CENTRAL INDEX KEY: 0001754163
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35892
FILM NUMBER: 19812475
MAIL ADDRESS:
STREET 1: SOVEREIGN HOUSE, VISION PARK, HISTON
CITY: CAMBRIDGE
STATE: X0
ZIP: CB24 9BZ
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GW PHARMACEUTICALS PLC
CENTRAL INDEX KEY: 0001351288
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: SOVEREIGN HOUSE
STREET 2: VISION PARK
CITY: HISTON, CAMBRIDGE CB24 9BZ
STATE: X0
ZIP: 00000
BUSINESS PHONE: 44 1223 266800
MAIL ADDRESS:
STREET 1: SOVEREIGN HOUSE
STREET 2: VISION PARK
CITY: HISTON, CAMBRIDGE CB24 9BZ
STATE: X0
ZIP: 00000
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-07
0
0001351288
GW PHARMACEUTICALS PLC
GWPH
0001754163
Tovey Christopher J.
SOVEREIGN HOUSE, VISION PARK, HISTON
CAMBRIDGE
X0
CB24 9BZ
UNITED KINGDOM
0
1
0
0
Chief Operating Officer
Ordinary Shares
2019-05-07
4
M
0
200736
0.0013
A
203239
D
Ordinary Shares
2019-05-07
4
S
0
200736
16.14
D
2503
D
Stock Options
0.0013
2019-05-07
4
M
0
7
0.00
D
2018-06-24
2025-06-24
Ordinary Shares
7
0
D
Stock Options
8.7901
2019-05-07
4
M
0
27924
0.00
D
2018-06-24
2025-06-24
Ordinary Shares
27924
0
D
Stock Options
0.0013
2019-05-07
4
M
0
10457
0.00
D
2019-02-15
2026-02-15
Ordinary Shares
10457
0
D
Stock Options
0.0013
2019-05-07
4
M
0
139420
0.00
D
2019-02-15
2026-02-15
Ordinary Shares
139420
0
D
Stock Options
3.3667
2019-05-07
4
M
0
7508
0.00
D
2019-02-15
2026-02-15
Ordinary Shares
7508
67000
D
Stock Options
0.0013
2019-05-07
4
M
0
6468
0.00
D
2019-01-06
2027-01-06
Ordinary Shares
6468
0
D
Stock Options
0.0013
2019-05-07
4
M
0
8952
0.00
D
2019-02-26
2028-02-26
Ordinary Shares
8952
0
D
Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.
Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.31 U.S. Dollars as of May 7, 2019.
Represented by ADSs. The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2019.
The exercise price reported is price per ordinary share converted from price per ADS.
/s/ Christopher J. Tovey
2019-05-09